• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Mitochondria at the Crossroads: Linking the Mediterranean Diet to Metabolic Health and Non-Pharmacological Approaches to NAFLD.线粒体处于十字路口:将地中海饮食与代谢健康及非酒精性脂肪性肝病的非药物治疗方法联系起来。
Nutrients. 2025 Mar 30;17(7):1214. doi: 10.3390/nu17071214.
2
Mediterranean diet and nonalcoholic fatty liver disease.地中海饮食与非酒精性脂肪性肝病。
World J Gastroenterol. 2018 May 21;24(19):2083-2094. doi: 10.3748/wjg.v24.i19.2083.
3
Targeting Mitochondria for the Prevention and Treatment of Nonalcoholic Fatty Liver Disease: Polyphenols as a Non-pharmacological Approach.靶向线粒体防治非酒精性脂肪性肝病:多酚作为一种非药物治疗方法。
Curr Med Chem. 2023;30(26):2977-2995. doi: 10.2174/0929867329666221007115809.
4
Mitochondrial biogenesis: pharmacological approaches.线粒体生物合成:药理学方法。
Curr Pharm Des. 2014;20(35):5507-9. doi: 10.2174/138161282035140911142118.
5
Hepatic Mitochondrial Defects in a Nonalcoholic Fatty Liver Disease Mouse Model Are Associated with Increased Degradation of Oxidative Phosphorylation Subunits.非酒精性脂肪性肝病小鼠模型中肝线粒体缺陷与氧化磷酸化亚基降解增加有关。
Mol Cell Proteomics. 2018 Dec;17(12):2371-2386. doi: 10.1074/mcp.RA118.000961. Epub 2018 Aug 31.
6
Mitochondrial metabolic dysfunction and non-alcoholic fatty liver disease: new insights from pathogenic mechanisms to clinically targeted therapy.线粒体代谢功能障碍与非酒精性脂肪性肝病:从发病机制到临床靶向治疗的新见解。
J Transl Med. 2023 Jul 28;21(1):510. doi: 10.1186/s12967-023-04367-1.
7
Mediterranean diet and nonalcoholic fatty liver disease: molecular mechanisms of protection.地中海饮食与非酒精性脂肪性肝病:保护的分子机制
Int J Food Sci Nutr. 2017 Feb;68(1):18-27. doi: 10.1080/09637486.2016.1214239. Epub 2016 Aug 2.
8
Phytotherapy using blueberry leaf polyphenols to alleviate non-alcoholic fatty liver disease through improving mitochondrial function and oxidative defense.利用蓝莓叶多酚进行植物疗法,通过改善线粒体功能和氧化防御来缓解非酒精性脂肪肝疾病。
Phytomedicine. 2020 Apr;69:153209. doi: 10.1016/j.phymed.2020.153209. Epub 2020 Mar 18.
9
Antioxidant dietary approach in treatment of fatty liver: New insights and updates.抗氧化饮食法治疗脂肪肝:新见解与新进展。
World J Gastroenterol. 2017 Jun 21;23(23):4146-4157. doi: 10.3748/wjg.v23.i23.4146.
10
Dihydromyricetin Ameliorates Nonalcoholic Fatty Liver Disease by Improving Mitochondrial Respiratory Capacity and Redox Homeostasis Through Modulation of SIRT3 Signaling.二氢杨梅素通过调节 SIRT3 信号改善线粒体呼吸能力和氧化还原稳态来改善非酒精性脂肪性肝病。
Antioxid Redox Signal. 2019 Jan 10;30(2):163-183. doi: 10.1089/ars.2017.7172. Epub 2018 Feb 21.

引用本文的文献

1
Ultra-Processed Foods and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): What Is the Evidence So Far?超加工食品与代谢功能障碍相关脂肪性肝病(MASLD):目前有哪些证据?
Nutrients. 2025 Jun 24;17(13):2098. doi: 10.3390/nu17132098.
2
2,5-Dihydroxybenzoic Acid Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease by Targeting the CCL2-CCR2 Axis to Reduce Lipid Accumulation.2,5-二羟基苯甲酸通过靶向CCL2-CCR2轴减少脂质积累来改善代谢功能障碍相关的脂肪性肝病。
Nutrients. 2025 May 28;17(11):1835. doi: 10.3390/nu17111835.

本文引用的文献

1
Atg5-deficient mesenchymal stem cells protect against non-alcoholic fatty liver by accelerating hepatocyte growth factor secretion.自噬相关蛋白5(Atg5)缺陷的间充质干细胞通过加速肝细胞生长因子分泌来预防非酒精性脂肪肝。
Cell Commun Signal. 2024 Dec 3;22(1):579. doi: 10.1186/s12964-024-01950-x.
2
Which dietary patterns fend off nonalcoholic fatty liver disease? A systematic review of observational and interventional studies.哪些饮食模式可预防非酒精性脂肪性肝病?观察性和干预性研究的系统评价。
BMC Nutr. 2024 Nov 28;10(1):153. doi: 10.1186/s40795-024-00961-8.
3
Targeting Mitochondrial Dysfunction for the Prevention and Treatment of Metabolic Disease by Bioactive Food Components.通过生物活性食品成分靶向线粒体功能障碍以预防和治疗代谢性疾病
J Lipid Atheroscler. 2024 Sep;13(3):306-327. doi: 10.12997/jla.2024.13.3.306. Epub 2024 Jun 17.
4
Daily Orange Consumption Reduces Hepatic Steatosis Prevalence in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: Exploratory Outcomes of a Randomized Clinical Trial.每日摄入橙子可降低代谢相关脂肪性肝病患者肝脂肪变性的发生率:一项随机临床试验的探索性结果。
Nutrients. 2024 Sep 20;16(18):3191. doi: 10.3390/nu16183191.
5
Chemometric study on the effect of cooking on bioactive compounds in tomato pomace enriched sauces.烹饪对富含番茄渣的调味汁中生物活性化合物影响的化学计量学研究。
NPJ Sci Food. 2024 Sep 2;8(1):58. doi: 10.1038/s41538-024-00300-y.
6
Hepatoprotective mechanisms of pomegranate bioactives on a murine models affected by NAFLD as analysed by MS-based proteomics: The mitochondria in the eye of the storm.基于 MS 蛋白质组学分析石榴生物活性物质对 NAFLD 模型小鼠的肝保护机制:风暴眼中的线粒体。
Food Res Int. 2024 Sep;192:114769. doi: 10.1016/j.foodres.2024.114769. Epub 2024 Jul 16.
7
Influence of Cooking Technique on Bioaccessibility of Bioactive Compounds in Vegetable Lentil Soup.烹饪技术对蔬菜扁豆汤中生物活性化合物生物可及性的影响
Foods. 2024 Jul 29;13(15):2405. doi: 10.3390/foods13152405.
8
Fruit and vegetable intake and the risk of non-alcoholic fatty liver disease: a meta-analysis of observational studies.水果和蔬菜摄入量与非酒精性脂肪性肝病风险:一项观察性研究的荟萃分析
Front Nutr. 2024 Jun 21;11:1398184. doi: 10.3389/fnut.2024.1398184. eCollection 2024.
9
Oleuropein, a Component of Extra Virgin Olive Oil, Improves Liver Steatosis and Lobular Inflammation by Lipopolysaccharides-TLR4 Axis Downregulation.油橄榄叶多酚,特级初榨橄榄油的一种成分,通过脂多糖-TLR4 轴下调改善肝脂肪变性和肝小叶炎症。
Int J Mol Sci. 2024 May 21;25(11):5580. doi: 10.3390/ijms25115580.
10
Cyanidin-3-O-Glucoside Alleviates Alcoholic Liver Injury via Modulating Gut Microbiota and Metabolites in Mice.矢车菊素 - 3 - O - 葡萄糖苷通过调节小鼠肠道微生物群和代谢产物减轻酒精性肝损伤。
Nutrients. 2024 Feb 29;16(5):694. doi: 10.3390/nu16050694.

线粒体处于十字路口:将地中海饮食与代谢健康及非酒精性脂肪性肝病的非药物治疗方法联系起来。

Mitochondria at the Crossroads: Linking the Mediterranean Diet to Metabolic Health and Non-Pharmacological Approaches to NAFLD.

作者信息

Mercurio Giovanna, Giacco Antonia, Scopigno Nicla, Vigliotti Michela, Goglia Fernando, Cioffi Federica, Silvestri Elena

机构信息

Department of Science and Technology, University of Sannio, Via De Sanctis, 82100 Benevento, Italy.

出版信息

Nutrients. 2025 Mar 30;17(7):1214. doi: 10.3390/nu17071214.

DOI:10.3390/nu17071214
PMID:40218971
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11990101/
Abstract

Nonalcoholic fatty liver disease (NAFLD) is a growing global health concern that is closely linked to metabolic syndrome, yet no approved pharmacological treatment exists. The Mediterranean diet (MD) emerged as a first-line dietary intervention for NAFLD, offering metabolic and hepatoprotective benefits. Now conceptualized as a complex chemical matrix rich in bioactive compounds, the MD exerts antioxidant and anti-inflammatory effects, improving insulin sensitivity and lipid metabolism. Mitochondria play a central role in NAFLD pathophysiology, influencing energy metabolism, oxidative stress, and lipid homeostasis. Emerging evidence suggests that the MD's bioactive compounds enhance mitochondrial function by modulating oxidative phosphorylation, biogenesis, and mitophagy. However, most research has focused on individual compounds rather than the MD as a whole, leaving gaps in understanding its collective impact as a complex dietary pattern. This narrative review explores how the MD and its bioactive compounds influence mitochondrial health in NAFLD, highlighting key pathways such as mitochondrial substrate control, dynamics, and energy efficiency. A literature search was conducted to identify relevant studies on the MD, mitochondria, and NAFLD. While the search was promising, our understanding remains incomplete, particularly when current knowledge is limited by the lack of mechanistic and comprehensive studies on the MD's holistic impact. Future research integrating cutting-edge experimental approaches is needed to elucidate the intricate diet-mitochondria interactions. A deeper understanding of how the MD influences mitochondrial health in NAFLD is essential for developing precision-targeted nutritional strategies that can effectively prevent and manage the disease.

摘要

非酒精性脂肪性肝病(NAFLD)是一个日益引起全球健康关注的问题,它与代谢综合征密切相关,但目前尚无获批的药物治疗方法。地中海饮食(MD)已成为NAFLD的一线饮食干预措施,具有代谢和肝脏保护作用。现在,MD被概念化为一种富含生物活性化合物的复杂化学基质,具有抗氧化和抗炎作用,可改善胰岛素敏感性和脂质代谢。线粒体在NAFLD病理生理学中起核心作用,影响能量代谢、氧化应激和脂质稳态。新出现的证据表明,MD的生物活性化合物通过调节氧化磷酸化、生物发生和线粒体自噬来增强线粒体功能。然而,大多数研究都集中在个别化合物上,而不是整个MD,这使得在理解其作为一种复杂饮食模式的总体影响方面存在空白。这篇叙述性综述探讨了MD及其生物活性化合物如何影响NAFLD中的线粒体健康,重点介绍了线粒体底物控制、动力学和能量效率等关键途径。我们进行了文献检索,以确定关于MD、线粒体和NAFLD的相关研究。虽然检索结果很有希望,但我们的理解仍然不完整,特别是当当前的知识受到关于MD整体影响的机制和全面研究缺乏的限制时。需要整合前沿实验方法的未来研究来阐明复杂的饮食-线粒体相互作用。深入了解MD如何影响NAFLD中的线粒体健康对于制定能够有效预防和管理该疾病的精准营养策略至关重要。